Showing results (621-630 of 663) with videos related to
Sort By:
Pageof 67
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2024
Correlation between progression-free and overall survival in patients with Hodgkin lymphoma: a comprehensive analysis of individual patient data from randomized German Hodgkin Study Group (GHSG) trialsP J Bröckelmann, H Müller, M Fuchs, et al.Alimentary Pharmacology & Therapeutics|February 2, 2018
Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleedingN Pfisterer, C Dexheimer, E-M Fuchs, et al.European Journal of Cancer (Oxford, England : 1990)|March 18, 2018
Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie'M Haas, J T Siveke, M Schenk, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2023
Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin's lymphoma: results from the randomized international GHSG HD18 trialJ Ferdinandus, H Müller, C Damaschin, et al.BMC Cancer|July 27, 2022
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancerG Sommerhäuser, A Kurreck, S Stintzing, et al.Obstetrics and Gynecology|May 28, 2020
Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) InfectionMaria Andrikopoulou, Nigel Madden, Timothy Wen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2025
Risk of disease progression in the first-line therapy of metastatic colorectal cancer to guide disease re-assessments - analysis of eleven trials by AIO and GONOM M Germani, V Heinemann, D Rossini, et al.Cell Host & Microbe|April 25, 2023
The natural product chlorotonil A preserves colonization resistance and prevents relapsing Clostridioides difficile infectionArne Bublitz, Madita Brauer, Stefanie Wagner, et al.ESMO Open|August 15, 2022
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)I Hartlapp, D Valta-Seufzer, J T Siveke, et al.Pageof 67